IRIS
SCICALI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.470
EU - Europa 1.361
AS - Asia 853
AF - Africa 281
SA - Sud America 223
Totale 5.188
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.427
IT - Italia 839
SG - Singapore 530
IE - Irlanda 238
BR - Brasile 208
CN - Cina 194
CI - Costa d'Avorio 181
SN - Senegal 76
VN - Vietnam 58
DE - Germania 55
UA - Ucraina 51
RU - Federazione Russa 45
CA - Canada 37
SE - Svezia 34
GB - Regno Unito 23
FI - Finlandia 20
NL - Olanda 19
HK - Hong Kong 14
NG - Nigeria 12
TR - Turchia 12
FR - Francia 11
UZ - Uzbekistan 10
IN - India 8
MA - Marocco 6
CH - Svizzera 5
PK - Pakistan 5
BG - Bulgaria 4
CL - Cile 4
PL - Polonia 4
AR - Argentina 3
BE - Belgio 3
TH - Thailandia 3
AT - Austria 2
AZ - Azerbaigian 2
CO - Colombia 2
GR - Grecia 2
IQ - Iraq 2
JP - Giappone 2
LB - Libano 2
MX - Messico 2
PE - Perù 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
HN - Honduras 1
HU - Ungheria 1
ID - Indonesia 1
IR - Iran 1
IS - Islanda 1
KE - Kenya 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MK - Macedonia 1
MN - Mongolia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SV - El Salvador 1
TG - Togo 1
TN - Tunisia 1
TZ - Tanzania 1
ZA - Sudafrica 1
Totale 5.188
Salva come PNG Salva come JPEG
Città #
Santa Clara 695
Chandler 434
Singapore 326
Chicago 269
Dublin 235
Abidjan 181
Civitanova Marche 152
Catania 134
Boardman 118
Ashburn 88
Rome 80
Dakar 76
Cambridge 66
Lawrence 60
Andover 58
Jacksonville 56
Dong Ket 51
Wilmington 42
Des Moines 34
Nanjing 28
Toronto 25
Bremen 24
Milan 22
Carrara 19
Padova 19
Beijing 17
Los Angeles 17
Lappeenranta 14
Messina 14
Palermo 14
Saint Petersburg 14
Houston 13
Abuja 12
Hong Kong 12
Menlo Park 12
Seattle 12
Shenyang 11
São Paulo 11
Belo Horizonte 10
Council Bluffs 10
Gravina di Catania 10
Hebei 10
Munich 9
San Mateo 9
Washington 9
Ottawa 8
Reggio Emilia 8
Bari 7
Hanoi 7
Istanbul 7
Pollenza 7
Enna 6
Helsinki 6
Leawood 6
Aci Sant'Antonio 5
Amsterdam 5
Brasília 5
Civitavecchia 5
Guangzhou 5
Jiaxing 5
Nanchang 5
Ragusa 5
Sankt Augustin 5
Shanghai 5
Tashkent 5
The Dalles 5
Tianjin 5
Woodbridge 5
Belpasso 4
Boydton 4
Cagliari 4
Curitiba 4
Giarre 4
London 4
Redmond 4
Rio de Janeiro 4
Salvador 4
San Francisco 4
Santiago 4
Betim 3
Camaçari 3
Contagem 3
Dearborn 3
Florence 3
Florianópolis 3
Goiânia 3
Jinan 3
Misterbianco 3
Moscow 3
Paternò 3
Pozzallo 3
Pune 3
San Giovanni la Punta 3
Sant'Ambrogio di Valpolicella 3
Shenzhen 3
Sriracha 3
Syracuse 3
São Bernardo do Campo 3
Tremestieri Etneo 3
Ann Arbor 2
Totale 3.770
Salva come PNG Salva come JPEG
Nome #
1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease 140
Controlling Nutritional Status (CONUT) Score as a Potential Prognostic Indicator of In-Hospital Mortality, Sepsis and Length of Stay in an Internal Medicine Department 102
Chronic exposure to palmitate impairs insulin signaling in an intestinal L-cell line: A possible shift from GLP-1 to glucagon production 102
HbA1c identifies subjects with prediabetes and subclinical left ventricular diastolic dysfunction 97
Analysis of S100A12 plasma levels in hyperlipidemic subjects with or without familial hypercholesterolemia 91
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 86
Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation 86
Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two-Lipid Center Real-World Experience 86
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 85
Atorvastatin but not pravastatin impairs mitochondrial function in human pancreatic islets and rat β-cells. Direct effect of oxidative stress 82
The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia 81
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 81
Trattamento dell’ipercolesterolemia nel soggetto con diabete mellito: Aggiornamento sugli approcci terapeutici 78
Cardiovascular Risk Profile in Subjects With Prediabetes and New-Onset Type 2 Diabetes Identified by HbA1c According to American Diabetes Association Criteria 77
Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 77
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 76
Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: a single lipid center real-world experience 74
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview 73
Effect of PCSK9 inhibitors on pulse wave velocity and monocyte-to-HDL-cholesterol ratio in familial hypercholesterolemia subjects: results from a single-lipid-unit real-life setting 73
High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes 72
Alterazioni lipidiche ed epatiche in soggetti con prediabete identificato in base all'emoglobina glicosilata 72
Impaired Glucagon Suppression And Reduced Insulin Sensitivity In Subjects With Prediabetes Undergoing Atorvastatin Therapy 72
Circulating coding and long non-coding rnas as potential biomarkers of idiopathic pulmonary fibrosis 72
New treatment options for lipid-lowering therapy in subjects with type 2 diabetes 71
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 71
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 71
Clinical and molecular biomarkers for diagnosis and staging of nafld 68
Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 66
An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects 66
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 64
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 64
Direct and indirect effects of sars-cov-2 pandemic in subjects with familial hypercholesterolemia: A single lipid-center real-world evaluation 64
HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients 63
Analysis of gingival crevicular fluid biomarkers in patients with metabolic syndrome 62
Direct effects of d-chiro-inositol on insulin signaling and glucagon secretion of pancreatic alpha cells 61
Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk 60
Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease 58
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 58
Left ventricular geometry and periodontitis in patients with the metabolic syndrome 57
High TG to HDL ratio plays a significant role on atherosclerosis extension in prediabetes and newly diagnosed type 2 diabetes subjects 57
High Glucose Exposure Impairs L-Cell Differentiation in Intestinal Organoids: Molecular Mechanisms and Clinical Implications 56
Molecular Effects of Chronic Exposure to Palmitate in Intestinal Organoids: A New Model to Study Obesity and Diabetes 55
Corticosteroid replacement therapy in hepatoadrenal syndrome: case report with a review of the literature. 55
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 55
Analysis of arterial stiffness and sexual function after adding on pcsk9 inhibitor treatment in male patients with familial hypercholesterolemia: A single lipid center real-world experience 55
Impact of high neutrophil-to-lymphocyte ratio on the cardiovascular benefit of PCSK9 inhibitors in familial hypercholesterolemia subjects with atherosclerotic cardiovascular disease: Real-world data from two lipid units 55
Detecting familial hypercholesterolemia by serum lipid profile screening in a hospital setting: Clinical, genetic and atherosclerotic burden profile 54
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study 54
PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy 52
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 51
Comparison of Total Cortisol, Free Cortisol, and Surrogate Markers of Free Cortisol in Diagnosis of Adrenal Insufficiency in Patients with Stable Cirrhosis. 51
Apolipoprotein AI and HDL are reduced in stable cirrhotic patients with adrenal insufficiency: a possible role in glucocorticoid deficiency 51
Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation 50
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 50
Increased Platelet Reactivity and Proinflammatory Profile Are Associated with Intima-Media Thickness and Arterial Stiffness in Prediabetes 50
L'emoglobina glicosilata, meglio della curva da carico, permette l'identificazione di soggetti con prediabete ed elevato rischio cardiovascolare 49
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 49
Achilles tendon ultrasonography in familial hypercholesterolemia: A sub‐study of the LIpid transPort disorders Italian GEnetic Network (LIPIGEN) 49
Studio dell'effetto incretinivo e della funzione beta cellulare in soggetti con prediabete e diabete di neo diagnosi 49
Mitochondrial RNAs as Potential Biomarkers of Functional Impairment in Diabetic Kidney Disease 48
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 47
Author Correction: Atorvastatin but Not Pravastatin Impairs Mitochondrial Function in Human Pancreatic Islets and Rat β-Cells. Direct Effect of Oxidative Stress 47
Proprotein convertase subtilisin kexin type 9 inhibitors reduce platelet activation modulating ox-LDL pathways 47
Acute hyperbilirubinemia determines an early subclinical renal damage: Evaluation of tubular biomarkers in cholemic nephropathy 47
Associations of pro-protein convertase subtilisin-like kexin type 9, soluble low-density lipoprotein receptor and coronary artery disease 44
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 43
Ankle-Brachial Index and cardiovascular events in atrial fibrillation: The ARAPACIS study 43
The impact of obesity and dyslipidemia on Remdesivir effectiveness in hospitalized patients with SARS-CoV-2-related pneumonia: An observational study 43
Evaluation of high-density lipoprotein-bound long non-coding RNAs in subjects with familial hypercholesterolaemia 41
May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects? 41
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study 40
Author's reply to: Arterial stiffness improvement after adding on PCSK9 inhibitors in patients with familial hypercholesterolemia, a letter from Papaioannou and colleagues 40
Identification of a New RNA and Protein Integrated Biomarker Panel Associated with Kidney Function Impairment in DKD: Translational Implications 39
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 39
Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units 39
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 39
Management of Statin Intolerant Patients in the Era of Novel Lipid Lowering Therapies: A Critical Approach in Clinical Practice 37
Cardiovascular risk management in type 2 diabetes mellitus: A joint position paper of the Italian Cardiology (SIC) and Italian Diabetes (SID) Societies 37
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 37
Implications of GLP-1 Receptor Agonist on Thyroid Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality and TSH Levels 34
PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk 34
Emerging Circulating Biomarkers in Atherosclerosis: From Molecular Mechanisms to Therapeutic Strategies 32
Clinical evaluation of bempedoic acid for the treatment of hyperlipidaemia 32
Endothelial Dysfunction and Heart Failure with Preserved Ejection Fraction—An Updated Review of the Literature 32
Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network 32
Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group 31
Is the relationship between erythropoiesis and renal function one of the secrets of extreme longevity? 31
Indirect Effects of the COVID-19 Pandemic on In-Hospital Outcomes among Internal Medicine Departments: A Double-Center Retrospective Study 31
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 31
Impatto del profilo lipidico sulla malattia aterosclerotica in due differenti coorti di pazienti ad alto rischio cardiovascolare 29
Advancements in risk stratification and management strategies in primary cardiovascular prevention 28
Malnutrition-Related Liver Steatosis, CONUT Score and Poor Clinical Outcomes in an Internal Medicine Department 28
Associations between Host Genetic Variants and Subgingival Microbiota in Patients with the Metabolic Syndrome 28
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group 25
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 24
The Lipoprotein Profile Evaluated by 1H-NMR Improves the Performance of Genetic Testing in Familial Hypercholesterolemia 16
Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis 16
Real-world efficacy of combination therapy with GLP1-RA and SGLT2-I in type 2 diabetes subjects with inadequate glucose control 14
Efficacy of combined therapy with GLP1-RA and SGLT2-I in poorly controlled type 2 diabetes 9
Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation 9
Totale 5.390
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.985
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.985
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202037 0 0 0 0 0 0 0 0 0 0 16 21
2020/2021268 7 16 12 5 47 15 19 3 14 37 31 62
2021/2022534 37 57 1 21 90 38 70 41 27 7 21 124
2022/20231.115 69 95 33 137 105 170 5 192 214 14 42 39
2023/2024798 37 118 50 27 45 165 52 89 10 27 104 74
2024/20252.398 70 400 138 261 554 390 134 77 145 226 3 0
Totale 5.405